BBWI vs KMB vs RAJAF Stock Comparison

Bath & Body Works, Kimberly Clark and TFA Therapeutics Prices as of Nov 13, 2026 Peers: Industry group
BBWI Bath & Body Works, Inc.
$21.38 +12.9% 1M -2.8% 1Y
Market cap
$4.41B
P/E
4.9x
Revenue (TTM)
$11.86B
Div. yield
-0.10%
Personal Care Products Consumer Staples
6 wins
KMB Kimberly Clark Corp
$109.43 +10.1% 1M +4.8% 1Y
Market cap
$37.02B
P/E
11.2x
Revenue (TTM)
$16.57B
Div. yield
0.05%
Personal Care Products Consumer Staples
4 wins
RAJAF TFA Therapeutics, Inc.
$9.18 0.0% 1M 0.0% 1Y
Market cap
$1.02B
P/E
–
Revenue (TTM)
—
Div. yield
–
Personal Care Products Consumer Staples
1 win

Head to Head

11 decided of 12

Bath & Body Works leads on 6 of the 12 questions below (Bath & Body Works 6, Kimberly Clark 4, TFA Therapeutics 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBBWIKMBRAJAFLeader
Larger companyMarket capitalisation $4.41B $37.02B $1.02B KMB
Cheaper on earningsLower P/E, profitable companies only 4.9x 11.2x -6,589x BBWI
Cheaper on forward earningsLower price / next fiscal year consensus EPS 7.6x 14.5x — BBWI
Faster revenue growthRevenue growth, trailing twelve months +92.8% +0.6% — BBWI
More profitableNet margin, trailing twelve months 8.7% 19.9% — KMB
Better return on capitalReturn on invested capital 68.8% 19.6% — BBWI
Less leveragedLower net debt / EBITDA 1.3x 1.5x — BBWI
Higher dividend yieldTrailing dividend yield -0.10% 0.05% — –
Better 1-year returnPrice return, last 12 months -2.8% +4.8% 0.0% KMB
Better 5-year returnAnnualised price return, 5 years -22.2%/yr -4.0%/yr — KMB
Less volatileAnnualised volatility, 1 year 62.1% 25.3% 0.0% RAJAF
Higher overall scoreMean of the five percentile scores vs peers 69/100 69/100 — BBWI

Percentile Scorecard

BBWIKMBRAJAF

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBBWIKMBRAJAF
Valuation 98 #2 of 55 74 #15 of 55 30 #39 of 55
Growth 69 #17 of 52 67 #18 of 52 –
Profitability 94 #4 of 50 82 #10 of 50 –
Financial Health 45 #33 of 59 50 #30 of 59 7 #55 of 59
Shareholder Returns 39 #20 of 32 71 #10 of 32 –
Overall 69 69 –
  • BBWI ranked among 60 companies in Household and Personal Products
  • KMB ranked among 60 companies in Household and Personal Products
  • RAJAF ranked among 60 companies in Household and Personal Products

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBBWIKMBRAJAFSPY
1 month +12.9%+10.1%0.0% -2.0%
3 months +10.1%-0.9%0.0% -2.8%
6 months +25.1%+14.1%0.0% +2.0%
Year to date +6.5%+8.5%0.0% +10.6%
1 year -2.8%+4.8%0.0% +12.2%
3 years -32.1%-9.7%— +68.1%
3 years, per year -12.1%-3.3%— +18.9%
5 years -71.4%-18.3%— +61.4%
5 years, per year -22.2%-4.0%— +10.1%
10 years -61.8%-3.1%— +248.5%
10 years, per year -9.2%-0.3%— +13.3%

Risk

MeasureBBWIKMBRAJAFSPY
Volatility, 1Y 62.1%25.3%0.0% 13.6%
Downside volatility, 1Y 64.1%24.6%— 13.9%
Beta vs S&P 500, 1Y 1.350.090.00 1.00
Return / volatility, 1Y -0.040.19— 0.90
Max drawdown, 5Y -81.1%-37.3%-18.7% -25.4%
From 52-week high -13.3%-4.6%0.0% -3.2%
52-week high $24.67$114.74$9.18 $779.14
52-week low $14.85$93.05$9.18 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBBWIKMBRAJAF
P/E now vs peer median 4.5xmedian 21.1x 11.0xmedian 21.1x -6,589xmedian 21.1x
P/S now vs peer median 0.4xmedian 2.2x 2.2xmedian 2.2x 819.1xmedian 2.2x
EV/EBITDA now vs peer median 3.3xmedian 14.0x 13.1xmedian 14.0x —median 14.0x
P/FCF now vs peer median 3.0xmedian 17.3x 18.7xmedian 17.3x -28,458xmedian 17.3x
P/B now vs peer median -4.1xmedian 1.9x 11.8xmedian 1.9x -1,908xmedian 1.9x
PEG now vs peer median 1.59median 0.87 0.46median 0.87 —median 0.87

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBBWIKMBRAJAF
Revenue $11.86B $16.57B –
Gross profit $5.13B $6.04B –
Operating income $1.65B $2.41B –
Net income $895.00M $3.34B –
Free cash flow $2.50B $1.94B –
EPS (diluted) $4.20 $9.90 –
Cash & equivalents – $1.87B $3.20K
Total debt – $6.49B $4.48M
Shares (diluted) 213.00M 333.70M 111.12M
Enterprise value $4.41B $32.96B $1.02B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBBWIKMBRAJAF
P/E 4.5x 11.0x -6,589x
P/FCF 3.0x 18.7x -28,458x
P/Operating cash flow 3.1x 10.8x –
P/S 0.4x 2.2x 819.1x
P/B -4.1x 11.8x -1,908x
P/Tangible book -3.5x 12.1x -1,908x
EV/EBITDA 3.3x 13.1x –
EV/EBIT 4.1x 17.0x –
EV/Revenue 0.6x 2.5x –
EV/FCF 4.9x 21.1x –
EV/Operating cash flow 5.2x 12.1x –
PEG (3Y EPS CAGR) 1.59 0.46 –

Growth

14 metrics
MetricBBWIKMBRAJAF
Revenue growth (1Y) 92.8% 0.6% –
Revenue CAGR (3Y) 24.0% -6.7% –
Gross profit growth (1Y) -1.8% 2.4% –
Gross profit CAGR (3Y) -0.2% -4.4% –
Operating income growth (1Y) -6.3% 6.4% –
Operating income CAGR (3Y) -3.8% 0.3% –
Net income growth (1Y) -4.3% 67.5% –
Net income CAGR (3Y) -1.4% 23.6% –
EPS growth (1Y) 0.0% 67.4% –
EPS CAGR (3Y) 2.8% 23.9% –
Operating cash flow growth (1Y) 39.6% 28.9% –
Operating cash flow CAGR (3Y) 2.2% 0.6% –
Free cash flow growth (1Y) 37.2% 16.3% –
Free cash flow CAGR (3Y) 2.6% -8.9% –

Profitability

14 metrics
MetricBBWIKMBRAJAF
Gross margin 43.5% 36.5% –
EBITDA margin 18.4% 19.0% –
Operating margin 14.7% 14.5% –
Pretax margin 11.2% 13.1% –
Net margin 8.7% 19.9% –
FCF margin 12.4% 11.7% –
Operating cash flow margin 11.7% 20.4% –
Return on equity – 134.8% –
Return on assets 29.5% 18.4% –
Return on invested capital 68.8% 19.6% –
Return on capital employed 51.7% 21.0% –
Asset turnover 2.3x 0.9x –
Cash conversion (OCF / net income) 1.3x 1.0x –
Stock comp / revenue 0.4% 0.8% –

Financial Health

11 metrics
MetricBBWIKMBRAJAF
Debt / assets 70.1% 36.6% 96.1%
Debt / equity -3.4x 2.1x -8.4x
Net debt / EBITDA 1.3x 1.5x –
Debt / FCF 2.5x 3.3x –
Liabilities / assets 120.5% 82.7% 111.5%
Equity / assets -20.5% 17.3% -11.5%
Interest coverage 22.8x 11.0x –
Current ratio 1.2x 0.9x 0.2x
Quick ratio 0.6x 6.7x 0.0x
Cash ratio 0.5x 0.3x 0.0x
Altman Z-score 3.56 3.71 –

Shareholder Returns

7 metrics
MetricBBWIKMBRAJAF
Dividend yield 3.7% 4.7% –
Net buyback yield -6.6% 0.0% –
Shareholder yield -2.8% 4.7% –
Payout ratio (earnings) 28.1% 50.6% –
Payout ratio (FCF) 19.8% 86.7% –
Dividend growth (1Y) 5.9% 2.2% –
Dividend CAGR (3Y) 3.9% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBBWIKMBRAJAF
Forward P/E 7.6xFY2026 14.5xFY2026 –
EPS, next fiscal year $2.81FY2026 $7.56FY2026 –
EPS growth, next FY -12.5%FY2026 +0.4%FY2026 –
EPS growth, the year after -5.3% -7.5% –
Revenue, next fiscal year $7.36BFY2026 $18.46BFY2026 –
Revenue growth, next FY +1.0%FY2026 +12.2%FY2026 –
Revenue growth, the year after +0.4% +87.4% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBBWIKMBRAJAF
Held by institutions 95.8% 96.8% –
Institutions holding 465 1,716 –
Change in shares held, QoQ +1.6% +9.1% –
Institutions buying 245 830 –
Institutions selling 171 622 –
Buyers to sellers 1.43 1.33 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BBWIKMBRAJAF
BBWI 1.00 0.19 –
KMB 0.19 1.00 –
RAJAF – – –

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BBWI, KMB and RAJAF?

Kimberly Clark (KMB) is the largest by market capitalisation: Bath & Body Works (BBWI) $4.41B, Kimberly Clark (KMB) $37.02B, TFA Therapeutics (RAJAF) $1.02B.

Which stock is cheaper, BBWI, KMB and RAJAF?

Bath & Body Works (BBWI) trades on the lowest price-to-earnings ratio (Bath & Body Works (BBWI) 4.9x, Kimberly Clark (KMB) 11.2x, TFA Therapeutics (RAJAF) -6,589x). On next year's consensus earnings, Bath & Body Works (BBWI) is cheapest (Bath & Body Works (BBWI) 7.6x, Kimberly Clark (KMB) 14.5x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Bath & Body Works (BBWI) grew revenue fastest over the trailing twelve months: Bath & Body Works (BBWI) +92.8%, Kimberly Clark (KMB) +0.6%.

Which company is more profitable?

Kimberly Clark (KMB) has the highest net margin (Bath & Body Works (BBWI) 8.7%, Kimberly Clark (KMB) 19.9%). On return on invested capital, Bath & Body Works (BBWI) leads (Bath & Body Works (BBWI) 68.8%, Kimberly Clark (KMB) 19.6%).

Which stock has performed better?

Over the past year Kimberly Clark (KMB) returned the most: Bath & Body Works (BBWI) -2.8%, Kimberly Clark (KMB) +4.8%, TFA Therapeutics (RAJAF) 0.0%. Over five years, Kimberly Clark (KMB) compounded fastest (Bath & Body Works (BBWI) -22.2%/yr, Kimberly Clark (KMB) -4.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Bath & Body Works (BBWI) -0.10%, Kimberly Clark (KMB) 0.05%. Bath & Body Works (BBWI) and TFA Therapeutics (RAJAF) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, TFA Therapeutics (RAJAF) has been the steadiest (Bath & Body Works (BBWI) 62.1%, Kimberly Clark (KMB) 25.3%, TFA Therapeutics (RAJAF) 0.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BBWI, KMB and RAJAF?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Bath & Body Works (BBWI) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.